These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 2981918)

  • 1. Antigen presentation by EBV-B cells to resting and activated T cells: role of interleukin 1.
    Chu ET; Lareau M; Rosenwasser LJ; Dinarello CA; Geha RS
    J Immunol; 1985 Mar; 134(3):1676-81. PubMed ID: 2981918
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanisms of the failure of resting B cells to present tetanus toxoid antigen to T cells.
    Brozek C; Umetsu D; Schneeberger E; Geha RS
    J Immunol; 1984 Mar; 132(3):1144-50. PubMed ID: 6607279
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of antigen uptake and presentation by Epstein-Barr virus-transformed human lymphoblastoid B cells.
    Chu E; Umetsu D; Lareau M; Schneeberger E; Geha RS
    Eur J Immunol; 1984 Apr; 14(4):291-8. PubMed ID: 6327319
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antigen presentation by human B cells: T cell proliferation induced by Epstein Barr virus B lymphoblastoid cells.
    Issekutz T; Chu E; Geha RS
    J Immunol; 1982 Oct; 129(4):1446-50. PubMed ID: 6286767
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antigen presentation by human dermal fibroblasts: activation of resting T lymphocytes.
    Umetsu DT; Katzen D; Jabara HH; Geha RS
    J Immunol; 1986 Jan; 136(2):440-5. PubMed ID: 3484491
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of interleukin 1 in antigen-specific T cell proliferation.
    Chu E; Rosenwasser LJ; Dinarello CA; Lareau M; Geha RS
    J Immunol; 1984 Mar; 132(3):1311-6. PubMed ID: 6198387
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stimulation of EBV-activated human B cells by monocytes and monocyte products. Role of IFN-beta 2/B cell stimulatory factor 2/IL-6.
    Tosato G; Gerrard TL; Goldman NG; Pike SE
    J Immunol; 1988 Jun; 140(12):4329-36. PubMed ID: 2836512
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inability of human alveolar macrophages to stimulate resting T cells correlates with decreased antigen-specific T cell-macrophage binding.
    Lyons CR; Ball EJ; Toews GB; Weissler JC; Stastny P; Lipscomb MF
    J Immunol; 1986 Aug; 137(4):1173-80. PubMed ID: 2426354
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Specific B lymphocytes efficiently pick up, process and present antigen to T cells.
    Lanzavecchia A; Bove S
    Behring Inst Mitt; 1985 Aug; (77):82-7. PubMed ID: 3002320
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Requirement of Ia-positive accessory cells in the MLR response against class II antigen on human B cell tumor line.
    Yamamoto M; Yano A
    J Immunol; 1985 Dec; 135(6):3887-96. PubMed ID: 2999233
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of human B lymphocytes: frequency of antigen-specific B cells triggered by alloreactive or by antigen-specific T cell clones.
    Lanzavecchia A; Parodi B; Celada F
    Eur J Immunol; 1983 Sep; 13(9):733-8. PubMed ID: 6604634
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antigen-specific B cells efficiently present low doses of antigen for induction of T cell proliferation.
    Malynn BA; Romeo DT; Wortis HH
    J Immunol; 1985 Aug; 135(2):980-8. PubMed ID: 2409164
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Idiotypic determinants on human T cells and modulation of human T cell responses by anti-idiotypic antibodies.
    Geha RS
    J Immunol; 1984 Oct; 133(4):1846-51. PubMed ID: 6206140
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human dendritic cells pulsed with autologous Epstein-Barr virus transformed B-cell lymphoblastoid cell (BCL) lysate elicit a BCL specific MHC-class II restricted T-cell response.
    Sugano M; Conway TF; Kelleher RJ; Sugiyama Y; Chen FA; Bankert RB; Bernstein SH
    J Exp Clin Cancer Res; 2001 Jun; 20(2):175-82. PubMed ID: 11484971
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alloantigen presentation by B cells: analysis of the requirement for B-cell activation.
    Wilson JL; Cunningham AC; Kirby JA
    Immunology; 1995 Nov; 86(3):325-30. PubMed ID: 8550066
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification and characterization of an Epstein-Barr virus-specific T-cell response in the pathologic tissue of a patient with Hodgkin's disease.
    Dolcetti R; Frisan T; Sjöberg J; De Campos-Lima PO; Pisa P; De Re V; Gloghini A; Rizzo S; Masucci MG; Boiocchi M
    Cancer Res; 1995 Aug; 55(16):3675-81. PubMed ID: 7627978
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of antigen processing and presentation by covalently linked complement C3b fragment.
    Jacquier-Sarlin MR; Gabert FM; Villiers MB; Colomb MG
    Immunology; 1995 Jan; 84(1):164-70. PubMed ID: 7890301
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytotoxic T cell recognition of Epstein-Barr virus-infected B cells. III. Establishment of HLA-restricted cytotoxic T cell lines using interleukin 2.
    Wallace LE; Rowe M; Gaston JS; Rickinson AB; Epstein MA
    Eur J Immunol; 1982 Dec; 12(12):1012-8. PubMed ID: 6297919
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Defective antigen presentation by human melanoma cell lines cultured from advanced, but not biologically early, disease.
    Alexander MA; Bennicelli J; Guerry D
    J Immunol; 1989 Jun; 142(11):4070-8. PubMed ID: 2469732
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autocrine models of B-lymphocyte growth. II. Interleukin-1 supports the proliferation of transformed lymphoblasts but not the stimulation of resting B cells triggered through their receptors for antigen.
    Gordon J; Guy G; Walker L
    Immunology; 1986 Mar; 57(3):419-23. PubMed ID: 3007333
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.